Apr 29 |
Stoke Therapeutics appoints CFO
|
Apr 29 |
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
|
Apr 25 |
Earnings Preview: Stoke Therapeutics, Inc. (STOK) Q1 Earnings Expected to Decline
|
Apr 17 |
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer
|
Apr 4 |
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Apr 4 |
Stoke Therapeutics: Positive Dravet Data Sends Shares Soaring, One For The Watchlist
|
Mar 28 |
Stoke Therapeutics prices upsized equity offering of $125M
|
Mar 28 |
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
|
Mar 27 |
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
|
Mar 26 |
Stoke Therapeutics announces proposed public offering worth $75M
|